Aortic Stenosis Market Report 2026

Aortic Stenosis Market Overview

• Aortic Stenosis market size has reached to $8.91 billion in 2025 • Expected to grow to $16.17 billion in 2030 at a compound annual growth rate (CAGR) of 12.6% • Growth Driver: Rising Prevalence Of Heart Diseases Fuels Growth In The Market • Market Trend: Advancements In Aortic Valve Technologies Accelerating Innovation In Treatment Solutions • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Aortic Stenosis Market?

Aortic stenosis is a condition where the aortic valve in the heart becomes narrowed, restricting blood flow from the left ventricle to the aorta and the rest of the body. It is often caused by age-relate valve calcification, congenital valve defects, or rheumatic fever. Aortic stenosis can lead to serious complications such as heart failure, which can be treated with medication or surgical interventions such as valve replacement. The main types of aortic stenosis are congenital aortic stenosis and acquired aortic stenosis. Congenital aortic stenosis refers to a narrowing of the aortic valve present at birth, which restricts blood flow from the heart's left ventricle to the aorta. The available treatments include surgical aortic valve replacement, transcatheter aortic valve replacement, and balloon aortic valvuloplasty. These are administered through various methods such as oral, parenteral, and implants. Distribution channels are categorized into offline and online platforms, while end users comprise hospital pharmacies, retail pharmacies, and online pharmacies.

What Is The Aortic Stenosis Market Growth Forecast?

The aortic stenosis market size is expected to see rapid growth in the next few years. It will grow to $16.17 billion in 2030 at a compound annual growth rate (CAGR) of 12.6%. The growth in the forecast period can be attributed to increasing investments in next-generation valve technologies, rising adoption of tavr procedures, expansion of outpatient cardiac care models, growing focus on early intervention strategies, increasing integration of digital cardiac monitoring tools. Major trends in the forecast period include increasing adoption of transcatheter valve replacement procedures, rising demand for minimally invasive cardiac interventions, growing use of advanced diagnostic imaging, expansion of personalized valve therapy solutions, enhanced focus on early disease detection.

Global Aortic Stenosis Market Segmentation

1) By Type: Congenital Aortic Stenosis, Acquired Aortic Stenosis 2) By Treatment: Surgical Aortic Valve Replacement, Transcatheter Aortic Valve Replacement, Balloon Aortic Valvuloplasty 3) By End User: Hospitals and Cardiac Centers, Ambulatory Surgical Centers, Cardiac Surgeons and Interventional Cardiologists Subsegments: 1) By Congenital Aortic Stenosis: Neonatal Aortic Stenosis, Infantile Aortic Stenosis, Juvenile Aortic Stenosis 2) By Acquired Aortic Stenosis: Age-Related Aortic Stenosis, Degenerative Aortic Stenosis, Rheumatic Aortic Stenosis

What Is The Driver Of The Aortic Stenosis Market?

The increasing prevalence of heart diseases is expected to propel the growth of the aortic stenosis market going forward. Heart diseases refer to a range of conditions that affect the heart's structure and function. These conditions can impact the heart's ability to pump blood effectively, leading to complications. The common heart diseases are coronary artery disease (CAD), heart failure, arrhythmias, valvular heart disease, cardiomyopathy, and more. Aortic stenosis involves narrowing the aortic valve, which impedes blood flow from the left ventricle to the aorta. This increased resistance forces the heart to work harder, potentially leading to heart failure and other cardiovascular complications over time. Proper treatment of aortic stenosis, such as valve replacement or TAVI, helps improve heart function and reduces the risk of severe heart disease outcomes. For instance, in January 2025, according to the British Heart Foundation, a UK-based cardiovascular research charity, approximately 7.6 million people in the UK are living with heart and circulatory diseases, including around 4 million males and 3.6 million females. These conditions account for about 27% of all deaths in the UK, leading to over 170,000 fatalities annually, equivalent to 480 deaths per day. Therefore, the increasing prevalence of heart diseases is driving the growth of the aortic stenosis industry.

Key Players In The Global Aortic Stenosis Market

Major companies operating in the aortic stenosis market are Abbott Laboratories, Medtronic plc, Edwards Lifesciences Corporation, Boston Scientific Corporation, Terumo Corporation, LivaNova PLC, CryoLife Inc, Anteris Technologies Ltd, Venus Medtech, Peijia Medical, MicroPort Scientific Corporation, Lepu Medical Technology Co Ltd, Symetis SA, Artivion Inc, HighLife SAS, Transcatheter Technologies GmbH, NaviGate Cardiac Structures Inc, Xeltis BV, Sorin Group, Meril Life Sciences Pvt Ltd, On-X Life Technologies Inc, Braile Biomédica, Colibri Heart Valve

Global Aortic Stenosis Market Trends and Insights

Major companies operating in the aortic stenosis market are focusing on developing innovative aortic valve technologies, such as transcatheter aortic valve implantation (TAVI) systems, to improve patient outcomes, reduce procedural risks, and enhance the overall effectiveness of treatment for aortic. The transcatheter aortic valve implantation (TAVI) system is a minimally invasive medical device that can replace a diseased aortic valve without open-heart surgery. For instance, in January 2023, Abbott Laboratories, a US-based medical device company, received approval for Navitor, a latest-generation transcatheter aortic valve implantation (TAVI) system from the U.S. Food and Drug Administration (FDA). Navitor features the NaviSeal fabric cuff to reduce or eliminate paravalvular leaks. The system's design, with leaflets within the native valve, aims to improve access to coronary arteries for future treatments of coronary artery disease.

What Are Latest Mergers And Acquisitions In The Aortic Stenosis Market?

In August 2024, Edwards Lifesciences, a US-based heart valve technologies company, acquired JC Medical for an undisclosed amount. With this acquisition, Edwards Lifesciences enhances its structural heart portfolio by adding the J-Valve system, a transcatheter aortic valve replacement (TAVR) technology for treating severe aortic regurgitation. JC Medical is a US-based medical device company specializing in the development of transcatheter aortic valve implantation (TAVI) systems to treat both aortic stenosis (AS) and aortic regurgitation (AR).

Regional Outlook

North America was the largest region in the aortic stenosis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Aortic Stenosis Market?

The aortic stenosis market consists of revenues earned by entities by providing services such as surgical treatments, transcatheter aortic valve replacement, balloon valvuloplasty and medical management. The market value includes the value of related goods sold by the service provider or included within the service offering. The aortic stenosis market includes sales of medical devices, diagnostic and monitoring tools and surgical instruments. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Aortic Stenosis Market Report 2026?

The aortic stenosis market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the aortic stenosis industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.